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Abstract
Leptospirosis is a zoonotic infection associated with severe diseases such as leptospirosis pulmonary haemorrhage syndrome (LPHS).
The cause of pulmonary haemorrhage is unclear. Understanding which mechanisms and processes are involved in LPHS will be impor-
tant in treatment regimens under development for this life-threatening syndrome. In the present study, we evaluated 30 lung specimens
from LPHS patients and seven controls using histology and immunohistochemistry (detection of IgM, IgG, IgA and C3) in order to
describe the pathological features associated with this syndrome. Immunoglobulin deposits were detected on the alveolar surface in 18/
30 LPHS patients. Three staining patterns were observed for the immunoglobulins and C3 in the lung tissues of LPHS patients: AS, deli-
cate linear staining adjacent to the alveolar surface, which was indicative of a membrane covering the luminal surface of type I and II
pneumocyte cells; S, heterogeneous staining which was sporadically distributed along the alveolar septum; and IA, weak, focal intra-alve-
olar granular staining. Human LPHS is associated with individual and unique histological patterns that differ from those of other causes
of pulmonary haemorrhage. In the present study, it was found that the linear deposition of immunoglobulins (IgA, IgG and IgM) and
complement on the alveolar surface may play a role in the pathogenesis of pulmonary haemorrhage in human leptospirosis.
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Introduction
More than 500 000 cases of leptospirosis are estimated to
occur worldwide each year [1]. Leptospirosis is an environ-
mentally transmitted zoonotic disease. The principal mode of
transmission is contact with water or soil contaminated with
urine from animals infected with the Leptospira bacterium
[1–3]. Infection entails a broad spectrum of clinical manifesta-
tions, ranging from self-limiting febrile illness to Weil’s disease,
which is the classic severe form of the disease, characterized by
jaundice, acute renal failure and bleeding. The Nicaraguan out-
break in 1995 raised awareness of the importance of leptospi-
rosis as a cause of a pulmonary haemorrhage syndrome [4].
Reports from Asia and the Americas now indicate that lepto-
spirosis has become a major cause of haemorrhagic fever [5–
10]. The fatality rates linked to the leptospirosis pulmonary
haemorrhage syndrome (LPHS) are >50% [6,7,10].
There is an urgent need to improve therapy and support-
ive care for patients with LPHS. Novel therapies such as
plasma exchange and corticotherapy may be beneﬁcial
[11,12]. Therefore, increased understanding of the disease
pathogenesis is crucial. It is generally believed that neither
thrombocytopenia nor the decrease in clotting factors in lep-
tospirosis patients is sufﬁcient on its own to account for the
observed bleeding diathesis [13–16]. Histological and elec-
tron microscopy studies in human and guinea pig models
were unable to demonstrate signiﬁcant intravascular thrombi
and small vessel ﬁbrin deposition [13,16,17].
Nally et al. reproduced the LPHS in a guinea pig model
[16] using Leptospira interrogans serovar Copenhagen strains
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isolated from Brazilian patients who died from haemorrhage
and acute respiratory failure [18]. This study demonstrated
that immunoglobulin and complement were deposited along
alveolar septa and that it could be associated with pulmonary
haemorrhage [16]. Also, immunoglobulin deposition on the
alveolar septum and alveolar space were observed in a
human case of LPHS [19]. However, other than in this single
case report [19], these ﬁndings have not been reported in
larger case series nor, as this one case suggests, has it been
established whether an autoimmune process does indeed
contribute to the pathogenesis of LPHS. Understanding
whether such processes found in experimental animals occur
in humans will be important in developing treatment regi-
mens for this life-threatening syndrome. In the present study,
we examined lung samples from 30 patients who died of
LPHS in Brazil, using histology and immunohistochemistry
(IHC) to determine whether the presence of immunoglobulin
and complement deposits on the alveolar surface was associ-
ated with this syndrome.
Patients and methods
The records of the Death Veriﬁcation Service from Depart-
ment of Pathology, Hospital das Clı´nicas, Faculdade de Medi-
cina da Universidade de Sa˜o Paulo were reviewed to identify
all deaths as a result of LPHS which occurred between 1 Jan-
uary 1988 and 1 January 2005. Conﬁrmation of leptospirosis
involved the following criteria: a > four-fold rise in the mic-
roagglutination titer; a single titer >1 : 400; and/or detection
of Leptospira in biopsy or autopsy specimens during immuno-
histochemical analysis.
In addition to analysis of autopsy specimens from LPHS
cases, autopsy specimens were evaluated as controls from
seven patients with pulmonary haemorrhage which was con-
ﬁrmed to be a result of other diseases (two patients with
acute pulmonary oedema associated with heart failure, three
patients with disseminated intravascular coagulation associ-
ated with sepsis and two patients with cirrhosis). Controls
were randomly selected from the records of the Death Veri-
ﬁcation Service of Sao Paulo state.
Information on demographics, past medical history, clinical
presentation, laboratory ﬁndings and outcome was extracted
from the medical records and computerized laboratory
records using a standardized data entry form.
Lung tissue samples were ﬁxed in neutral, buffered formal-
dehyde (4%) (Medical Chemical Corporation, Torrance, CA,
USA) and processed according to standard methods which
included embedding in parafﬁn, sectioning into 4-lm serial
sections and staining with haematoxylin and eosin (H&E).
Lung sections were processed for immunohistochemical anal-
yses using polyclonal antibodies. Antibody binding and visuali-
zation were carried out using the streptavidin-biotin
peroxidase method, with an endogenous biotin blocking sys-
tem (DAKO, Carpinteria, CA, USA). The following poly-
clonal antibodies were used in this process: polyclonal rabbit
anti-human IgA (A0262/Dako), polyclonal rabbit anti-human
IgM (A0425/Dako), polyclonal rabbit anti-human IgG (A0423/
Dako) and polyclonal rabbit anti-human C3C (A0062/Dako).
The same protocol was used to detect Leptospira antigens
with a polyclonal rabbit antibody [17,20,21].
Initially one observer (J.C.) analysed six paired H&E- and
IHC-stained lung sections to determine the principal features
related to LPHS. Subsequently, the 37 (30 LPHS patients and
seven controls) sections were analysed by one independent
pathologist blinded to patient identity, diagnosis and clinical
course (R.A.B) using semi-quantitative scores: 0 = absence;
1 = mild; 2 = moderate; and 3 = intense. In the alveolar
space and the alveolar septae, the observers scored the sec-
tions for macrophages, lymphocytes, neutrophils, plasma cells
and eosinophils. In the alveolar wall and lumen, they scored
the sections for necrosis, regeneration of pneumocytes, giant
cells, oedema, haemorrhage and hyaline membranes. The
sections were also scored for septum thickness, oedema,
capillary congestion and ﬁbrosis. The pathologist scored the
following ﬁndings based on standardized scoring protocols
previously used [22].
Data were entered into EPIDATA (version 3.0; U.S. Cen-
ters for Disease Control and Prevention) and analysed using
the SAS system (version 9.1; SAS Institute, Cary, NC, USA).
Results are expressed as the median and interquartile range,
or as percentages when appropriate. Differences in fre-
quency were evaluated using the v2 test or Fisher’s exact
test. Medians were compared using the Mann–Whitney–Wil-
coxon test. The study protocol was approved by the Investi-
gational Review Board of the Hospital das Clı´nicas, Sa˜o Paulo
University and the institutional ethical guidelines were fol-
lowed.
Results
During the study period, we identiﬁed necropsies from 37
LPHS patients. Necropsies from seven patients were
excluded because the parafﬁn blocks showed evidence of tis-
sue autolysis, there was inappropriate ﬁxation with artefacts
or there was typical bacterial infection. This selection
resulted in a ﬁnal sample of 30 leptospirosis patients who
presented with well-deﬁned clinical and histological evidence
of lung involvement.
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Twenty three out of 30 (77%) leptospirosis patients were
men, and the median age was 48.5 years (range from 19 to
70). The median duration of symptoms before hospital
admission was 6 days (range from 4 to 13). The median
platelet count and serum creatinine levels were 54 000 cells/
mm3 (range from 10 000 to 222 000) and 6.1 mg/dL (range
from 0.6 to 14.2), respectively. All patients required mechan-
ical ventilation, which was performed for a median duration
of 2 days (range from 0 to 13). Dialysis was performed in 19
out of 30 (63%) cases. The median duration of hospital stay
was 3 days (range from 1 to 6) (Table 1).
The LPHS patients (n = 30) differed from control pulmo-
nary haemorrhage patients (n = 7) in several features: the
presence of moderate to high levels of macrophages in the
alveolar space (77% vs. 29%, respectively; p 0.02), the pres-
ence of the focal hyaline membrane on the alveolar surface
(100% vs. 0%; p <0.01), extensive necrosis and regeneration
of pneumocyte II cells (100% vs. 0%; p <0.01) and the pres-
ence of plasma cells in the alveolar septum (77% vs. 29%,
respectively; p 0.02) (Table 2).
No statistically signiﬁcant differences were observed in
the number of other cells in the alveolar septae between
LPHS and control patients. Intact leptospires were rarely
detected in the lungs of LPHS patients. Reactive debris of
granular material associated with macrophages cells was
occasionally detected. Leptospiral antigen was not correlated
with the intensity of the lesions. None of the patients
showed microscopic evidence of disseminated intravascular
coagulation.
Lung tissues from 30 LPHS patients and seven controls
were examined for the presence of IgM, IgG, IgA and the
complement component C3. Three staining patterns were
observed for each immunoglobulin and C3 in the lung tis-
sue from the LPHS patients (Fig. 1): AS, delicate linear
staining adjacent to the alveolar surface, which was indica-
tive of a membrane covering the luminal surface of type I
and II pneumocyte cells; S), heterogeneous staining which
was sporadically distributed along the alveolar septum; and
IA, weak, focal intra-alveolar granular staining. As shown in
Fig. 1, AS-type staining was present in lung tissue samples
with diffuse alveolar haemorrhage. This was the most fre-
quent staining pattern observed (12/17, 71%). S-type stain-
ing and a mix of S- and AS-type staining were observed in
tissues showing mild and/or moderate alveolar haemor-
rhage (5/17, 29%). The S type was not predominantly
associated with either capillaries or epithelial basal mem-
branes.
Out of the 30 LPHS lung tissue samples, 18 were positive
for IgA, 17 for IgM, 16 for IgG, and 17 for C3. All 17 C3-
positive samples were also positive for at least two Ig classes
(Table 2).
Patients with more recent pulmonary haemorrhage dem-
onstrated a higher frequency of C3 and IgG depositions (11/
14 and 10/14, respectively) than patients who presented with
pulmonary haemorrhage with phagocytosis of haemosiderin
pigment (6/16 and 6/16, respectively) (p 0.02) (data not
shown).
After separating LPHS patients into two groups based on
the median duration of mechanical ventilation, we found that,
in patients who used mechanical ventilation for 2 days or less,
there was a lower frequency of specimens with macrophages
in the alveolar lumen than in patients who were on mechani-
cal ventilation for more than 2 days (31% vs. 80%, p 0.04).
Discussion
LPHS is the major cause of death in patients with leptospiro-
sis. The case fatality rate in patients with LPHS in Brazil
ranges from 55 to 74% [5,7]. Understanding the pathogenesis
of this disease would thus provide a basis for designing effec-
tive therapeutic interventions and allow the identiﬁcation of
biomarkers related to the severity of leptospirosis. The pres-
ent study suggests that membranous depositions of linear im-
munoglobulins (IgA, IgG, IgM) and complement on an
alveolar surface may trigger fatal pulmonary haemorrhage in
human leptospirosis.
TABLE 1. Clinical and laboratory ﬁndings for patients with
leptospirosis pulmonary haemorrhagic syndrome
Clinical characteristics
Age, median (IR) 48.5 (40–56)
Male gender, n(%) 23/30 (77%)
Duration of symptoms, median (IR) 6 days (4–7)
Clinical symptoms on admission
Fever, n(%) 26/26 (100%)
Muscle pain, n(%) 23/24 (96%)
Headache, n(%) 17/23 (74%)
Nausea or vomiting, n(%) 13/24 (54%)
Diarrhoea, n(%) 6/6 (25%)
Laboratory values
Haematocrit %, median (IR) 26 (20–30)
Leucocytes, cells/mm3,median (IR) 1.6 · 104 (1.1–1.9 · 104)
Platelets, cells/mm3,median (IR) 5.4 · 104 (3.6–10.0 · 104)
Serum creatinine, mg/dL, median (IR) 6.1 (4.0–7.6)
Serum bilirubin, mg/dL, median (IR) 18.7 (10.6–25.0)
AST, mg/dL, median (IR) 105 (51–221)
ALT, mg/dL, median (IR) 77 (31–142)
Prothrombin time (INR), median (IR) 1.35 (1.00–1.40)
Partial thromboplastin ratio, median (IR) 1.1 (0.9–1.5)
Clinical course
Use of vasoactive drugs, n(%) 22127 (81%)
Duration of mechanical ventilation,
median (IR)
2 day (0–5)
Dialysis, n(%) 19127 (70%)
Duration of hospitalization, median (IR) 3 days (1–6)
AST, aspartate aminotransferase; ALT, alanine aminotransferase; INR, Interna-
tional normalized ratio; IR, Interquartile range.
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Immunoglobulin deposits were detected in 18/30 LPHS
patients, but were not detected in any of the seven control
haemorrhagic lung samples. In all 17 cases in which C3 depo-
sition was present, there was also deposition of IgM, IgG and
IgA. The most common staining pattern observed was a lin-
ear deposition adjacent to the alveolar surface. The S-type
staining was less commonly observed and may have reﬂected
the initial event that resulted in immunoglobulin and comple-
ment deposition on the alveolar surface. Lung tissue from
leptospirosis and control patients displayed IA-type staining,
which was most likely related to the non-speciﬁc immuno-
globulin and C3 staining in the alveolar space that was ﬁlled
by cells and plasma components.
The linear deposit pattern (AS-type staining) appeared to
cover type I and II pneumocyte cells, leading to the hypothe-
sis that such deposits could interfere with the epithelial bar-
rier. The injury to, and loss of epithelial integrity in, type I
and II cells disrupt normal epithelial ﬂuid transport and
impair the removal of oedema ﬂuid from the alveolar space
[23]. Moreover, injury to type II cells could reduce the pro-
duction and turnover rate of surfactant, as well as reduce
the capacity of oxygen and carbonic gas exchange
[24]. Together, these events could result in diffuse alveolar
haemorrhage.
Human LPHS is associated with unique histological pat-
terns that differ from other causes of pulmonary haemorrhage
such as bleeding diathesis, venous hypertension, other infec-
tions, tumour, collagen diseases, pulmonary haemorrhagic
syndrome and diffuse alveolar damage (DAD) [25]. The path-
ological diagnosis for acute-phase DAD is based on the
presence of hyaline membranes associated with intra-alveolar
red cells and neutrophilis [26]. The LPHS patients, in addi-
tion to having immunoglobulin and complement deposition,
also displayed pathological characteristics of DAD [27].
Little information regarding the pathological mechanism of
LPHS is available. Some clinical leptospirosis manifestations
are related to immunological responses such as in uveitis,
arthritis and aseptic meningitis [28–31]. Four previous stud-
ies have demonstrated the presence of anticardiolipin anti-
bodies in leptospirosis patients, and one series of cases
found a correlation between the presence of these antibod-
ies in the sera and severe complications from leptospirosis
[32–35]. Finally, Abdulkader et al. [36] demonstrated that
anti-Leptospira antibody levels are likely to be positively cor-
related with pulmonary haemorrhage.
Recently, Nally et al. [16] validated a guinea pig model for
LPHS studies. They suggested that the pathogenic mecha-
nisms involved in LPHS best ﬁt with a model of linear immu-
TABLE 2. Clinical and microscope char-
acteristics of 30 fatal cases of proven
human leptospirosis
Alveolar
space
IHC
Number Age Gender MV PI/II RPH M N L IgA IgM IgG C3
2 70 M 0 + + 3 0 1 + + + +
3 33 M 8 + ) 3 1 1 ) ) ) )
5 59 M 5 + ) 2 1 1 ) ) ) )
7 54 M 2 + ) 2 0 1 ) ) ) )
8 20 M 3 + + 2 1 1 + + + +
10 52 M 6 + ) 2 0 1 + + + +
11 31 M 1 + + 1 0 1 + + ) +
13 58 M 4 + ) 2 1 1 ) ) ) )
17 22 M 7 + ) 3 2 1 ) ) ) )
18 22 F 0 + + 1 0 1 + + + +
19 30 M 5 + + 2 0 1 + + + +
20 69 M 1 + + 2 0 1 + + + +
21 56 M 0 + + 2 1 1 + + + +
22 63 M 2 + ) 3 1 1 ) ) ) )
23 19 F 0 + ) 1 0 1 IC IC IC IC
24 27 F 0 + ) 2 0 1 IC IC IC IC
27 56 M 0 + + 2 1 1 + + + +
28 48 F 0 + + 1 0 1 + ) ) )
32 21 M 1 + + 1 1 1 + + + +
34 40 M 0 + + 1 0 0 IC IC IC IC
35 55 F 1 + + 1 1 1 + + + +
36 53 F 10 + ) 3 1 1 + + + +
37 54 M 0 + ) 2 0 1 ) ) ) )
38 44 M 2 + + 2 1 1 IC IC IC IC
42 40 M 8 + ) 2 0 1 + + + +
43 35 F 2 + ) 2 1 1 + + + +
44 40 M 13 + ) 2 1 1 ) ) ) )
45 53 M 0 + ) 3 1 1 + + + +
46 49 M 0 + + 2 0 1 + + + +
47 59 M 0 + ) 2 0 1 + + + +
M, male; F, female; +, positive; ), negative; IC, inconclusive; MV, days of mechanical ventilation; PI/II, type I and
II pneumocyte cells necrosis and regeneration; RPH, rRecent pulmonary haemorrhage; M, N, and L, semi-quan-
titative presence of macrophages, lymphocytes and neutrophils in the alveolar space.
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noglobulin and complement deposition along the alveolar
septum as occurs in Goodpasture’s syndrome or anti- glo-
merular basement membrane disease. As stated by these
authors, electron microscopy studies were unsuccessful in
conﬁrming the deposition of immunoglobulins in the capillary
alveolar basal membrane. Also, histological examination of
renal tissues did not demonstrate any pathological character-
istics of Goodpasture’s disease [16]. Regarding the involve-
ment of endothelial cells in the pathogenesis of LPHS, human
and experimental studies did not ﬁnd any pathological fea-
tures such as endothelial cell necrosis, rupture, thrombus or
exposed subendothelial collagen that are characteristic of
vasculitis [16,17].
In our study, the majority of patient lung samples pre-
sented immunoglobulin and complement deposition adjacent
to the alveolar surface correlated with intensive necrosis of
type I and II cells. Remarkably, it was not associated with the
alveolar septum and the alveolar basal membrane. Therefore,
the epithelial barrier seems to be more affected than endo-
thelial cells in human LPHS.
Based on these ﬁndings, we proposed that LPHS has
unique pathological features not seen in other pulmonary
haemorrhagic syndromes. We speculated that the initial
increase in vascular permeability as a result of endothelial
activation [17,37], overproduction of nitric oxide [38,39] and
enlarged open junctions [17,40] would permit IgM, IgG and
IgA leakage into the alveolar space. The S-type staining could
reﬂect this initial phase of immunoglobulin leakage through
the alveolar septum. The immunglobulin deposition against
IgM, IgG and IgA deposition 
on alveolar septum and surface 
of  type I and II pneumocyte
Macrophages 
migration
Increase in vascular 
permeability
Epithelial necrosis
Haemophagocytosis
Type II pneumocyte
regeneration
Cleanup of deposited C3
Endothelial activation
Overproduction of 
nitric oxide
Complement
activation
Alveolar haemorrhage
Leptospirosis
pulmonary 
haemorrhage 
syndrome
FIG. 2. Proposed pathogenic mechanism involved in leptospirosis
pulmonary haemorrhage syndrome (LPHS).
(a) (b) (c) (d)
HE
IgG
C3C
FIG. 1. Alveolar haemorrhage in leptospirosis pulmonary haemorrhage syndrome (LPHS) and control patients, as detected by histology and
immunohistochemistry in the alveolar area (Magniﬁcation, 400·). (a) Lung from control patients with diffuse alveolar haemorrhage (HE) showing
an absence of immunoglobulin and C3 deposition; (b) Lung from LPHS patients showing diffuse alveolar haemorrhage (HE) and a delicate linear
immunoglobulin and C3 deposition that is adjacent to the alveolar surface (AS staining pattern); (c) Lung from LPHS patients showing alveolar
haemorrhage (HE) and mixed AS and S staining pattern; and (d) Lung from LPHS patients (HE) showing haemorrhage and random, multifocal
staining along the alveolar septum (S staining pattern). HE = haematoxylin & eosin.
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type I and II pneumocyte cells could mediate the complement
activation with C3 deposition. This could then lead to epi-
thelial cell necrosis with cell leakage and haemorrhage into
the alveolar lumen (Fig. 2). The reasons for the failure to
detect C3 in 13 out of the 30 infected lung tissues are
unclear, but this may reﬂect a cleanup of deposited C3 by
the macrophage cells in the alveolar lumen, as the absence
of C3 deposits correlated with an increase of mononuclear
cells in the alveolar lumen in patients with increased mechan-
ical ventilation time. Alternatively, the absence of C3 depos-
its could be explained by the intrinsically short half-life of
C3C [41].
Although it is clear that antibodies and C3 are deposited
along the alveolar surface, additional evaluation will be neces-
sary to exclude the possibility that some cellular remnants
related to cell activation could cause the non-speciﬁc deposi-
tion of complement and/or immunoglobulin [17,37,42]. Test-
ing the sera of LPHS patients against normal lung tissues
would allow the veriﬁcation of the speciﬁcity of autoantibod-
ies to alveolar components such as type I and II pneumo-
cytes.
Further studies to characterize this apparent autoimmune
response and, perhaps, to identify the autoantibody involved,
could help to diagnose patients with an increased risk of
developing LPHS. Moreover, if an autoimmune process were
the cause of haemorrhagic complications in human leptospi-
rosis, effective therapies may involve removing autoantibod-
ies from the blood and decreasing their production.
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